Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine-Reference-Cited by-同舟云学术

Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine

Published:2015-11-17 Issue:1 Volume:12 Page:132-139
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Vesikari Timo,Forsten Aino,Bianco Veronique,Van der Wielen Marie,Miller Jacqueline M

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2015.1058457

Reference26 articles.

1. Meningococcal Disease

2. Global epidemiology of meningococcal disease

3. Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

4. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

5. A surveillance network for meningococcal disease in Europe

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination;Expert Review of Vaccines;2024-06-07

2. Real-world impact and effectiveness of MenACWY-TT;Human Vaccines & Immunotherapeutics;2023-08

3. A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12–14-month-old children;Vaccine;2023-01

4. Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy;Vaccines;2022-05-14

5. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile;Human Vaccines & Immunotherapeutics;2021-12-10